Top Tweets for #SignificantRevenue

over 1 year ago

#tradingfloorai | #OPTI | #StrongSales #SignificantRevenue #SalesGrowth #RevenueGrowth | Here is a summary of the commercial update from OptiBiotix Health PLC for the financial year ended December 31, 2024: - The company reports good progress on its main strategic objectives for 2024, including expanding partnerships and sales in the USA and Asia, investing in e-commerce channels, and growing sales of final branded and white-label products. - Sales momentum continued with a 56% increase in orders placed by the end of 2024, and a 35% increase in delivered sales. Q1 2025 sales orders have already surpassed H1 2024, marking a record start to the year. - The company has cleared a significant stock overhang from previous years, which will lead to improved gross margins and sales revenues in 2025. - E-commerce sales saw a 134% increase in 2024, with strong performance on Amazon (156% growth) and in China (28% growth). The company has transitioned to the FBA model on Amazon, improving delivery times and subscription rates. - In North America, OptiBiotix secured its first order from Daily Nouri in Q4 2024 and launched FeelFull prebiotic lemonade. Nouri has already placed multiple repeat orders and expects to reach its annual forecast by July 2025. - The company is working with two additional partners in the USA, including a NASDAQ-listed e-commerce company and a major player in the weight management market, with product launches expected in 2025. - OptiBiotixs business in India made significant progress with the partnership with Morepen and the launch of LightLife in December 2024. The product range has been successful, and reorders have been received in Q1 2025. - The company expects 2025 to be a record year, with strong sales across e-commerce, India, USA, and Asia. The aim is to achieve cash flow positivity in 2026. - OptiBiotix has a strong balance sheet and cash position, with no debt, and a solid pipeline of existing and new customers. The companys shareholdings in ProBiotix Health plc and SkinBioTherapeutics plc are also appreciating in value. - CEO Stephen OHara expresses confidence in the companys progress, highlighting the successful launches with new accounts and the strong start to 2025 with a robust order book and financial position. Read More@: https://t.co/WMJL6q4T4T

225

Top Tweets for #SignificantRevenue

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users